Important Information

THIS WEBSITE IS INTENDED FOR INSTITUTIONAL INVESTORS who are U.S. residents ONLY; not intended for access or distribution to retail investors.

 

In order to access the Capital Group U.S. Institutional website (the “Site”), please read the following information and affirm by clicking the accept button that you have read and understand the information provided.

 

You must attest that you meet the qualifications of an institutional investor as described herein and accept these Terms and Conditions in order to access the Site. Some content may require additional registration for access.

 

The Site is solely intended for U.S. residents who are institutional investors or are acting on behalf of an institutional investor who has agreed to these Terms and Conditions. Institutional investors include, but are not limited to any person acting on behalf of/any pension fund, financial intermediary, consultant, endowment and foundation, bank, savings and loan association, insurance company, investment company registered under the Investment Company Act of 1940, investment adviser registered with the U.S. Securities and Exchange Commission or under applicable state law, government entity, entity with total assets of at least $50 million, employee benefit or qualified retirement plan with at least 100 participants, defined contribution/benefit plan, and qualified client or purchaser as defined by the U.S. Securities and Exchange Commission. By agreeing to these Terms and Conditions you are affirming your understanding that the Site is not intended for retail investors, individual plan participants or others who may not possess the financial sophistication to independently understand the content nor should it be redistributed to such persons.

 

You understand that the Site does not constitute advice of any nature, including fiduciary investment advice by Capital Group or its associates.

 

The reference to “Capital Group” used herein includes The Capital Group Companies, Inc., and its affiliates.

Categories
U.S. Equities
Can the U.S. maintain its market dominance?
Anne-Marie Peterson
Equity Portfolio Manager
Chris Buchbinder
Equity Portfolio Manager
David Polak
Equity Investment Director

Is a shake-up in the global equities market underway? It’s been top of mind for many investors amid a broad sell-off of America's technology giants and a rotation into certain non-U.S. equity markets.


After closing at a record high on February 19, the S&P 500 Index tumbled 10% through mid-March but has clawed back some of those losses. Year to date through March 31, the S&P 500 is down 5%, while the Nasdaq Composite is off 10%. And the high-profile Magnificent Seven group of stocks have tumbled 16% this year, hit by worries over massive spending on artificial intelligence, following the shock emergence of DeepSeek, a startup in China.


By comparison, international stocks have shined. The MSCI ACWI World ex-USA Index has gained 7% and the MSCI Europe Index has risen 12%.


While there are some interesting investment opportunities in Europe and Asia, as well as companies with dominant global market positions in several industries, there is a diverse set of growth candidates among U.S. large caps outside the Mag 7.


“I wouldn’t discount the power of U.S. equities just yet,” says Anne-Marie Peterson, principal investment officer of The Growth Fund of America. “American innovation is thriving across industries due to a culture that fosters entrepreneurialism, the ability to access capital and attract top-rate talent.


“While certain Mag 7 companies may not offer the best relative returns longer term, I’m optimistic that the U.S. is the best hunting ground to find the next wave of large cap companies that can expand in market value.”


The ongoing correction in the S&P 500 is a reminder that constructing a U.S. portfolio limited in exposure to only a couple dominant factors can result in elevated concentration risks and high valuations. Instead, investors should consider how they could capture U.S. growth more broadly.


U.S. stocks have delivered outsized gains since 2014

 The line chart shows 10-year cumulative returns and annualize returns for four indexes: the S&P 500, MSCI Japan, MSCI Europe and MSCI EM from 2014 to 2024. All the indexes have experienced significant increase in the returns, MSCI EM by 43%, the MSCI Europe by 63%, MSCI Japan by 83% and S&P 500 leading them at 243% by the 10-year metric. The chart also shows the annualized returns of these indexes: the MSCI EM at 3.6%, MSCI Europe at 5%, MSCI Japan at 6.2% and S&P 500 at 13.1%. This trend indicates that U S stocks have far outpaced other regions over the past 10 years.

Sources: Capital Group, MSCI, S&P Global Ratings. Data as of December 31, 2024. 

Drivers of U.S. dominance remain intact 


The U.S. equity market has been the clear winner for many years. So what’s driven the dominance?


Exceptional earnings growth has been one catalyst. In the recovery following the great financial crisis of 2008 and 2009, U.S. companies generated earnings that far exceeded non-U.S. companies, supporting multiple expansion. And by 2024, that earnings gap reached its widest level in 12 years.


U.S. companies have posted stronger earnings growth

The line chart shows the trailing earnings per share (EPS) for MSCI All-Country World ex US and MSCI USA indexes from 2007 to 2025. The trend shows that EPS in U.S. companies surpassed the EPS of global companies throughout the period.

Source: Eikon Datastream. Trailing earnings per share = Rolling 12-month earnings per share based on operational earnings rebased at 100. Data from January 11, 2007, to January 11, 2025. 

All in, the U.S. has exhibited stronger productivity growth compared to most nations. A large labor pool and large capital expenditure cycles are among many factors contributing to such productivity. The U.S. has also generally leaned towards deregulation. And companies have historically rewarded shareholders through capital allocation and incentivized employees.


Companies can also have first mover advantage helped by a more benign regulatory environment and strong consumer purchasing power. Waymo, Alphabet's self-driving vehicle business, is one example. Waymo has tested robotaxis in a few major U.S. cities, reaching 4 million passenger rides last year, with plans to enter Austin and Atlanta this year. 


Why Mag 7 returns may diverge


Long before the rise of tech giants such as NVIDIA and Meta, U.S. market indices were dominated by the likes of ExxonMobil, Intel, General Electric and Citigroup. History has shown that leaders of one decade may not translate to the next.


“We've seen other periods of innovation, and innovation doesn't always equal returns for investors. And I think we may be reaching one of those periods of time where the leading technology companies may not be the best stocks to invest in,” says Chris Buchbinder, portfolio manager with The Growth Fund of America.


The shift to AI from cloud computing is likely to result in new competitive dynamics and differentiated return profiles among U.S. tech giants. AI is requiring far more capital investment than cloud technology did 10 years ago. Cloud computing itself may become a lower margin business due to increasing competition. On the upside, the technological benefits of AI could be leveraged by a wider group of companies to their advantage.


“We’ve been in a 15-year cycle and now things are changing, whether it’s the technology, the cost of capital due to higher interest rates or the realignment of global supply chains. As a growth investor, I believe a wider array of U.S. large caps can benefit from these shifts,” Peterson said. 


Still, individual companies within the Magnificent Seven group may continue to provide investors with superior returns and earnings growth. But we think investors should take a broader view going forward. 


Seek diversification in a concentrated market


The current crop of megacap tech stocks exemplifies U.S. dominance. However, there are opportunities to discover scalable and dominant businesses in other industries.


Costco has built a durable model in the club grocery business and developed an online sales platform to fend off competition from Amazon in grocery. Costco’s valuation has steadily increased over time as investors have shown faith in its longstanding business model. About 10 years ago, Costco had a P/E ratio of about 30x versus 54x currently.


U.S. equities have consistently delivered high returns on equity

The line chart shows the forward return on equities (ROE) percentages for the S&P 500, MSCI Europe, MSCI All-Country Asia Ex Japan and MSCI Japan. It shows the trend across the past 10 years, which illustrates that S&P 500 has generated the highest return on equity followed by MSCI Europe, MSCI AC Asia ex Japan and MSCI Japan. All four indexes experienced a significant decrease in returns around 2020 and regained gradual increase thereafter. However, the S&P 500 experiences a greater rise over the period.

Source: FactSet. Data from January 2010 to December 2024. Past results are not predictive of results in future periods.

Companies that are less capital intensive but can benefit or leverage AI’s development may be potential diversification candidates. Take silicon wafer design company Synopsys. It’s not a household name when it comes to technology stocks. But the nearly 40-year-old firm may receive interest from companies designing their own chips for AI applications.


Importantly, America’s preference for deregulation to foster competition and innovation, paired with a large consuming population, enables companies to achieve scale and mass adoption. 


Uber has made rapid gains in ridesharing and food delivery since launching in 2010. Uber completed its IPO in 2019, and given its success and continued growth, the company was added to the S&P 500 Index in December 2023 and the Dow Jones Transportation Average the following year.


DoorDash, a peer in the food delivery industry, recently joined the S&P 500, building on consumer demand and ease of use, akin to Uber. Airbnb is another example in the rental home business for vacations and short-term accommodations.


Not to be forgotten are industrials. The group generally expands at a rate above GDP growth. And now, reshoring has added additional growth prospects. Another advantage: Some companies have built up strong defensible businesses that are global, scalable and not susceptible to disruption. Plus, the integration of more advanced software is transforming traditional manufacturing processes. 


Innovation could spark resurgence in health care


In health care, AI is playing a role in helping to speed up drug development. While government policy has negatively impacted share prices after a strong run during COVID, we could be on the verge of a golden era of drug discovery. Some of this potential growth may be underestimated by the broader market. 


Health care appears historically undervalued

The line chart shows price-to-earnings (P/E) ratio of S&P 500 Health Care Index versus the S&P 500 Index from 2009 to 2024. The P/E ratio averages 0.92. The chart illustrates above average P/E from 2011 to 2015, dropping below average from 2016 to 2018.  P/E rose above average in 2019 but eventually lagged in 2020 and 2021. After gaining some momentum in 2023 the latest P/E as of March 27, 2025, stands at 0.84, below the average.

Sources: Capital Group, FactSet, Standard & Poor's. NTM = next twelve months. Relative P/E ratio represents the ratio between the 12-month forward P/E for the S&P 500 Health Care Sector (classified as members of the Global Industry Classification Standard) vs. the broader S&P 500 Index. Data as of March 27, 2025.

Investors poured an incredible amount of capital into the biotech and pharmaceutical industries over the past several years, resulting in the creation of intellectual property and know-how that will likely be improved upon for years to come. As such, there’s potentially an explosion of new therapeutic opportunities coming over the next decade.


“Since the pandemic, health care has lagged as an industry, but the pace of innovation's been almost as good as the technology industry. It's been quite incredible,” Buchbinder said. “Health care is a sector where the valuations don't reflect the level of enthusiasm in some of the technology and AI-related stocks.”


There are also other attractive areas. For instance, hospital chain HCA Healthcare has built a network of irreplaceable assets and contains significant pricing power with insurers. Now, the company seeks to leverage AI to drive earnings growth without significant capex. The latter is key as some investors express concern around capital intensity and the commoditization of AI.


Non-U.S. companies have exposure to U.S. growth


Many multinationals listed outside the U.S. generate large pools of revenue from outside their country of domicile.


Gaining exposure to this broader range of stocks, potentially at lower valuations, can be a way for investors to tap into the U.S. growth story without unnecessary concentration risks. Given stocks in regions outside the U.S. generally trade at much lower valuations, there is potential for equities to re-rate higher.


Stronger earnings growth is projected for international markets. Consensus projects earnings for the MSCI ACWI ex-USA Index to rise 11.5% and 9.8% for MSCI EAFE Index (developed international), based on FactSet data as of March 25. These indexes are more weighted to heavy industry, energy, materials and chemicals than the S&P 500 Index.


Beneficiaries could be those involved in the upgrade of U.S. physical infrastructure and building new manufacturing sites as part of reshoring efforts.  For example, Taiwan-based TSMC, the world’s largest semiconductor manufacturer, and European industrials such as Siemens AG or Schneider, are among companies participating in this fiscal spending wave. 


Take a broader view of U.S. growth


The opportunities to capture U.S. growth are broad. It may include tech leaders, but also diversification in areas such as industrials, health care and consumer discretionary.


The U.S. equity market has created a record of superior returns based on exceptional earnings growth that has attracted higher valuations. More agile resource allocation, a favorable regulatory environment and the scalability of a large single domestic market have also supported returns historically.


While many investors have recently expressed optimism around growth in non-U.S. markets, such as India and Japan, the DNA of U.S. markets remains intact.


Projected earnings for the S&P 500 remain robust at 11% this year. But with valuations at 20 times earnings on a 12-month forward basis, versus the 10-year average of 18 times, growth will come at a price. Investors will have to carefully weigh the challenges against the opportunities. 



Anne-Marie Peterson is an equity portfolio manager with 30 years of investment industry experience (as of 12/31/2024). She holds a bachelor’s degree in economics from the University of California, Irvine. She also holds the Chartered Financial Analyst® designation. 

Chris Buchbinder is an equity portfolio manager with 29 years of investment industry experience (as of 12/31/2024). He holds a bachelor’s degree in economics and international relations from Brown University.

David Polak is an investment director with 41 years of investment industry experience (as of 12/31/2024). He holds a bachelor’s degree in economics from University College London graduating with honors.


Past results are not predictive of results in future periods.

 

Capex: Capital expenditure.

 

Forward return on equity refers to an estimate of a company's future profitability based on its expected net income and shareholders' equity, rather than actual past performance.

 

Magnificent Seven = Apple, Microsoft, Amazon, NVIDIA, Alphabet, Tesla and Meta.

 

MSCI AC Asia ex Japan Index captures large- and mid-cap representation across developed markets countries (excluding Japan) and emerging markets countries in Asia.

 

MSCI All Country World Index (ACWI) ex USA Index captures large- and mid-cap representation across 22 of 23 developed markets countries (excluding the US) and 24 emerging market countries. 

 

MSCI EAFE® (Europe, Australasia, Far East) Index is a free-float-adjusted market-capitalization-weighted index designed to measure developed equity market results, excluding the United States and Canada. 

 

MSCI Emerging Markets Index is a free-float-adjusted market-capitalization-weighted index designed to measure equity market results in the global emerging markets, consisting of more than 24 emerging market country indexes. 

 

MSCI Europe Index is designed to measure the performance of equity markets in 15 developed countries in Europe.

 

MSCI Japan Index is designed to measure the performance of the large- and mid-cap segments of the Japanese market.

 

The MSCI USA Index is designed to measure the performance of the large- and mid-cap segments of the US market.

 

S&P 500 Index is a market-capitalization-weighted index based on the results of 500 widely held common stocks. 

Don’t miss out

Get the Capital Ideas newsletter in your inbox every other week

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.
Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.
Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility. These risks may be heightened in connection with investments in developing countries.
Investing in developing markets may be subject to additional risks, such as significant currency and price fluctuations, political instability, differing securities regulations and periods of illiquidity, which are detailed in the fund's prospectus. Investments in developing markets have been more volatile than investments in developed markets, reflecting the greater uncertainties of investing in less established economies. Individuals investing in developing markets should have a long-term perspective and be able to tolerate potentially sharp declines in the value of their investments.
The indexes are unmanaged and, therefore, have no expenses. Investors cannot invest directly in an index.
MSCI has not approved, reviewed or produced this report, makes no express or implied warranties or representations and is not liable whatsoever for any data in the report. You may not redistribute the MSCI data or use it as a basis for other indices or investment products.
Each S&P Index ("Index") shown is a product of S&P Dow Jones Indices LLC and/or its affiliates and has been licensed for use by Capital Group. Copyright © 2025 S&P Dow Jones Indices LLC, a division of S&P Global, and/or its affiliates. All rights reserved. Redistribution or reproduction in whole or in part is prohibited without written permission of S&P Dow Jones Indices LLC.
Statements attributed to an individual represent the opinions of that individual as of the date published and do not necessarily reflect the opinions of Capital Group or its affiliates. This information is intended to highlight issues and should not be considered advice, an endorsement or a recommendation.
All Capital Group trademarks mentioned are owned by The Capital Group Companies, Inc., an affiliated company or fund. All other company and product names mentioned are the property of their respective companies.
Use of this website is intended for U.S. residents only.
Capital Client Group, Inc.
This content, developed by Capital Group, home of American Funds, should not be used as a primary basis for investment decisions and is not intended to serve as impartial investment or fiduciary advice.